Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Puma Biotechnology stock has a target of 7.00, which predicts an increase of 150.90% from the current stock price of 2.79.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$7.00	$7.00	$7.00	$7.00
Change	+150.90%	+150.90%	+150.90%	+150.90%

* Price targets were last updated on Aug 2, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for PBYI is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	May '24	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+150.90%	Aug 2, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+150.90%	Jul 26, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+150.90%	Jun 4, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+150.90%	Jun 3, 2024
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+150.90%	May 20, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

222.33M

Decreased by -5.65%

from 235.64M

Revenue Next Year

211.85M

Decreased by -4.71%

from 222.33M

EPS This Year

0.26

Decreased by -41.29%

from 0.45

EPS Next Year

0.20

Decreased by -23.68%

from 0.26

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	272.26M	225.11M	253.16M	228.03M	235.64M	222.33M	211.85M	209.41M
Revenue Growth	8.47%	-17.32%	12.46%	-9.92%	3.34%	-5.65%	-4.71%	-1.15%
EPS	-1.95	-1.52	-0.72	0.00	0.45	0.26	0.20	0.21
EPS Growth	-	-	-	-	1,022,625.00%	-41.29%	-23.68%	4.55%
Forward PE	-	-	-	-	-	10.56	13.84	13.24
No. Analysts	-	-	-	-	-	5	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	231.0M	238.5M	253.0M
Avg	222.3M	211.9M	209.4M
Low	211.6M	182.3M	166.6M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	-2.0%	7.3%	19.4%
Avg	-5.6%	-4.7%	-1.2%
Low	-10.2%	-18.0%	-21.4%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	0.29	0.59	0.85
Avg	0.26	0.20	0.21
Low	0.25	-0.05	-0.25

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	-35.4%	122.6%	321.8%
Avg	-41.3%	-23.7%	4.6%
Low	-45.6%	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.